AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 12002834 — intervention group
Group type: COMPARATOR
Intervention: occlusal splints and physical therapy (group III)
Number of subjects: 72
Study 12002834 — intervention group
Group type: EXPERIMENTAL
Intervention: occlusal splints, medical, and physical therapy (group IV)
Number of subjects: 72
Study 10207532 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine/thymol-containing dental varnish (Cervitec)
Number of subjects: 15
Study 10207532 — intervention group
Group type: COMPARATOR
Intervention: Placebo varnish without active ingredients
Number of subjects: 15
Study 7796342 — intervention group
Group type: EXPERIMENTAL
Intervention: Single beam DXA scans
Number of subjects: 36
Study 7796342 — intervention group
Group type: EXPERIMENTAL
Intervention: Fan beam DXA scans
Number of subjects: 36
Study 2223143 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral melphalan (0.25 mg/kg/day) with oral prednisone (2 mg/kg/day)
Number of subjects: 81
Study 2223143 — intervention group
Group type: COMPARATOR
Intervention: Intravenous melphalan (0.125 mg/kg/day) with oral prednisone (2 mg/kg/day)
Number of subjects: 81
Study 333855 — intervention group
Group type: EXPERIMENTAL
Intervention: Bromocriptine (2.5 mg - 40 mg)
Number of subjects: 20
Study 333855 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 333855 — intervention group
Group type: EXPERIMENTAL
Intervention: Bromocriptine
Number of subjects: 20
Study 29271835 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic Exercise (AE)
Number of subjects: 10
Study 29271835 — intervention group
Group type: EXPERIMENTAL
Intervention: Strength Exercise (SE)
Number of subjects: 10
Study 29271835 — intervention group
Group type: COMPARATOR
Intervention: Control (CTL)
Number of subjects: 10
Study 28538781 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive cycling exercise combined with conventional physical therapy (5 days per week)
Number of subjects: 38
Study 28538781 — intervention group
Group type: COMPARATOR
Intervention: Conventional physical therapy (control group)
Number of subjects: 38
Study 28538781 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive cycling exercise combined with conventional physical therapy
Number of subjects: 38
Study 25475930 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical disc arthroplasty (CDA)
Number of subjects: 4061
Study 25475930 — intervention group
Group type: COMPARATOR
Intervention: Anterior cervical discectomy and fusion (ACDF)
Number of subjects: 4061
Study 23107931 — intervention group
Group type: EXPERIMENTAL
Intervention: web‐based expert system (QuitCoach)
Number of subjects: 3530
Study 23107931 — intervention group
Group type: EXPERIMENTAL
Intervention: text messaging program (onQ)
Number of subjects: 3530
Study 23107931 — intervention group
Group type: EXPERIMENTAL
Intervention: both as an integrated package
Number of subjects: 3530
Study 23107931 — intervention group
Group type: COMPARATOR
Intervention: control condition informed of a static website
Number of subjects: 3530
Study 20925442 — intervention group
Group type: EXPERIMENTAL
Intervention: Vardenafil ODT (10 mg)
Number of subjects: 3
Study 20925442 — intervention group
Group type: COMPARATOR
Intervention: Vardenafil FCT (film-coated tablet)
Number of subjects: 3
Study 20925442 — intervention group
Group type: EXPERIMENTAL
Intervention: Vardenafil ODT with food
Number of subjects: 3
Study 20925442 — intervention group
Group type: EXPERIMENTAL
Intervention: Vardenafil ODT in men aged ≥65 years
Number of subjects: 3
Study 19047077 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal CD4 count <200 during pregnancy
Number of subjects: 0
Study 19047077 — intervention group
Group type: EXPERIMENTAL
Intervention: Earlier breastfeeding cessation
Number of subjects: 0
Study 19047077 — intervention group
Group type: EXPERIMENTAL
Intervention: Low CD4 count
Number of subjects: 0
Study 19047077 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional Cox proportional hazards model
Number of subjects: 0
Study 17298968 — intervention group
Group type: EXPERIMENTAL
Intervention: Thrombolysis (TL) in community hospital
Number of subjects: 850
Study 17298968 — intervention group
Group type: COMPARATOR
Intervention: Interhospital transfer for primary percutaneous coronary intervention (p-PCI)
Number of subjects: 850
Study 15114797 — intervention group
Group type: EXPERIMENTAL
Intervention: Adult learning theory-based curriculum (PG)
Number of subjects: 0
Study 11554127 — intervention group
Group type: EXPERIMENTAL
Intervention: Azathioprine 100 mg/day for 6 weeks
Number of subjects: 33
Study 11554127 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisone
Number of subjects: 33
Study 11554127 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Number of subjects: 33
Study 11554127 — intervention group
Group type: COMPARATOR
Intervention: All groups
Number of subjects: 33
Study 9630326 — intervention group
Group type: EXPERIMENTAL
Intervention: CsA at a dosage of 1 mg/kg/die (CsA1)
Number of subjects: 59
Study 9630326 — intervention group
Group type: COMPARATOR
Intervention: CsA at a dosage of 3 mg/kg/die (CsA3)
Number of subjects: 59
Study 7834056 — intervention group
Group type: EXPERIMENTAL
Intervention: Saliva from healthy individuals
Number of subjects: 35
Study 7834056 — intervention group
Group type: COMPARATOR
Intervention: Saliva from patients with periodontal disease
Number of subjects: 35
Study 3050268 — intervention group
Group type: EXPERIMENTAL
Intervention: High NaCl diet (20 g/day)
Number of subjects: 15
Study 3050268 — intervention group
Group type: COMPARATOR
Intervention: Low NaCl diet (2 g/day)
Number of subjects: 15
Study 31783267 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile community learning (MCL) programme in case management (CM)
Number of subjects: 48
Study 31783267 — intervention group
Group type: COMPARATOR
Intervention: Control group (comparison group)
Number of subjects: 48
Study 30928294 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized perioperative ventilatory strategy (intraoperative recruitment maneuvers, individualized positive end-expiratory pressure, postoperative high-flow nasal cannula)
Number of subjects: 1380
Study 30928294 — intervention group
Group type: COMPARATOR
Intervention: Conventional lung-protective ventilation
Number of subjects: 1380
Study 29354989 — intervention group
Group type: EXPERIMENTAL
Intervention: Abdominal acupuncture
Number of subjects: 61
Study 29354989 — intervention group
Group type: COMPARATOR
Intervention: Western medication (Pinaverium bromide tablet, 50 mg, 3 times a day)
Number of subjects: 61
Study 25230980 — intervention group
Group type: EXPERIMENTAL
Intervention: Polypill (hydrochlorothiazide, aspirin, atorvastatin, and either enalapril or valsartan)
Number of subjects: 8410
Study 25230980 — intervention group
Group type: COMPARATOR
Intervention: Minimal care (non-pharmacological preventive interventions)
Number of subjects: 8410
Study 23360891 — intervention group
Group type: EXPERIMENTAL
Intervention: PhysioDirect services
Number of subjects: 1506
Study 23360891 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1506
Study 22050134 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 rpm group
Number of subjects: 20
Study 22050134 — intervention group
Group type: COMPARATOR
Intervention: 50 rpm group
Number of subjects: 20
Study 18811828 — intervention group
Group type: EXPERIMENTAL
Intervention: 6% hydroxyethyl starch solution 130/0.42 (HES)
Number of subjects: 50
Study 18811828 — intervention group
Group type: COMPARATOR
Intervention: 4% modified fluid gelatin (GEL)
Number of subjects: 50
Study 16543549 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical therapy arm of the National Emphysema Treatment Trial
Number of subjects: 609
Study 16543549 — intervention group
Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 609
Study 16543549 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxygen utilization
Number of subjects: 609
Study 16543549 — intervention group
Group type: EXPERIMENTAL
Intervention: Total lung capacity % predicted
Number of subjects: 609
Study 16543549 — intervention group
Group type: EXPERIMENTAL
Intervention: Residual volume % predicted
Number of subjects: 609
Study 16543549 — intervention group
Group type: EXPERIMENTAL
Intervention: Maximal cardiopulmonary exercise testing workload
Number of subjects: 609
Study 16543549 — intervention group
Group type: EXPERIMENTAL
Intervention: Proportion of emphysema in the lower lung zone versus the upper lung zone
Number of subjects: 609
Study 16543549 — intervention group
Group type: EXPERIMENTAL
Intervention: Upper‐to‐lower‐lung perfusion ratio
Number of subjects: 609
Study 16543549 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified BODE index
Number of subjects: 609
Study 16543549 — intervention group
Group type: EXPERIMENTAL
Intervention: FEV1
Number of subjects: 609
Study 12767651 — intervention group
Group type: EXPERIMENTAL
Intervention: Amiodarone
Number of subjects: 103
Study 12767651 — intervention group
Group type: COMPARATOR
Intervention: Implantable cardioverter-defibrillator (ICD)
Number of subjects: 103
Study 12767651 — intervention group
Group type: COMPARATOR
Intervention: ICD
Number of subjects: 103
Study 10694609 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified ultrafiltration
Number of subjects: 38
Study 10694609 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 38
Study 9384477 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose chemotherapy (HDC) with carmustine (300 mg/m2 x 1), etoposide (150 mg/m2 twice a day x 4 days), cytarabine (100 mg/m2 twice a day x 4 days), and cyclophosphamide (35 mg/kg x 4 days) followed by infusion of unmanipulated PBSC.
Number of subjects: 83
Study 9384477 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose chemotherapy (HDC) with PBSC infusion for patients who had failed primary induction chemotherapy (28 patients).
Number of subjects: 83
Study 9384477 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose chemotherapy (HDC) with PBSC infusion for patients in untreated first relapse (27 patients).
Number of subjects: 83
Study 9384477 — intervention group
Group type: COMPARATOR
Intervention: High-dose chemotherapy (HDC) with PBSC infusion for patients who had reinduction attempts prior to receiving mobilization chemotherapy (18 patients).
Number of subjects: 83
Study 1585757 — intervention group
Group type: EXPERIMENTAL
Intervention: Micanol (new dithranol formulation)
Number of subjects: 59
Study 1585757 — intervention group
Group type: COMPARATOR
Intervention: Dithranol 1% in petrolatum
Number of subjects: 59
Study 1585757 — intervention group
Group type: COMPARATOR
Intervention: Dithranol 1% in Amitase stick
Number of subjects: 59
Study 1585757 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 59
Study 4004200 — intervention group
Group type: EXPERIMENTAL
Intervention: Succinate limitation
Number of subjects: 0
Study 4004200 — intervention group
Group type: EXPERIMENTAL
Intervention: Other limitation (possibly sulphate limitation)
Number of subjects: 0
Study 30575682 — intervention group
Group type: EXPERIMENTAL
Intervention: High-salt diet (>12 g/day) with NTG
Number of subjects: 18
Study 30575682 — intervention group
Group type: EXPERIMENTAL
Intervention: High-salt diet (>12 g/day) without NTG
Number of subjects: 18
Study 30575682 — intervention group
Group type: COMPARATOR
Intervention: Low-salt diet (<3 g/day) with NTG
Number of subjects: 18
Study 30575682 — intervention group
Group type: COMPARATOR
Intervention: Low-salt diet (<3 g/day) without NTG
Number of subjects: 18
Study 30575682 — intervention group
Group type: EXPERIMENTAL
Intervention: High-salt diet (>12 g/day) with large body weight change
Number of subjects: 18
Study 30575682 — intervention group
Group type: EXPERIMENTAL
Intervention: High-salt diet (>12 g/day) with small body weight change
Number of subjects: 18
Study 28840638 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking combined with resting
Number of subjects: 81
Study 28840638 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking combined with balneotherapy
Number of subjects: 81
Study 28840638 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined resting and balneotherapy
Number of subjects: 81
Study 28840638 — intervention group
Group type: COMPARATOR
Intervention: Resting only
Number of subjects: 81
Study 26498451 — intervention group
Group type: EXPERIMENTAL
Intervention: Fractional CO2 laser treatment
Number of subjects: 30
Study 24825768 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxycycline in Group 1 (40 patients)
Number of subjects: 110
Study 24825768 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxycycline in Group 2 (15 patients)
Number of subjects: 110
Study 24825768 — intervention group
Group type: COMPARATOR
Intervention: Standard therapy in Group 1 (37 patients)
Number of subjects: 110
Study 24825768 — intervention group
Group type: COMPARATOR
Intervention: Standard therapy in Group 2 (18 patients)
Number of subjects: 110
Study 22687786 — intervention group
Group type: EXPERIMENTAL
Intervention: rosuvastatin 10 mg/day
Number of subjects: 40
Study 22687786 — intervention group
Group type: EXPERIMENTAL
Intervention: rosuvastatin 40 mg/day
Number of subjects: 40
Study 20664537 — intervention group
Group type: EXPERIMENTAL
Intervention: Oltipraz (30-90 mg single dose; 60 mg b.i.d. or 90 mg q.d. for 24 weeks)
Number of subjects: 0
Study 18034258 — intervention group
Group type: EXPERIMENTAL
Intervention: Coblator
Number of subjects: 40
Study 18034258 — intervention group
Group type: COMPARATOR
Intervention: Bipolar scissors
Number of subjects: 40
Study 15639067 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual misoprostol 800 mug
Number of subjects: 10
Study 15639067 — intervention group
Group type: COMPARATOR
Intervention: Buccal misoprostol 800 mug
Number of subjects: 10
Study 12048051 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional transcranial Doppler sonography
Number of subjects: 20
Study 12048051 — intervention group
Group type: EXPERIMENTAL
Intervention: Line bisection task
Number of subjects: 20
Study 11476263 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuing education workshops for rating-scale training (4 different workshops)
Number of subjects: 27
Study 9129767 — intervention group
Group type: EXPERIMENTAL
Intervention: LDL apheresis (Liposorber system, Kanegafuchi Chemical Industrial Company LTD, Osaka, Japan)
Number of subjects: 2
Study 8435265 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol 3 mg kg-1
Number of subjects: 102
Study 8435265 — intervention group
Group type: COMPARATOR
Intervention: Thiopentone 5 mg kg-1
Number of subjects: 102
Study 2448425 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% hydroxyethylstarch (HES), 500 ml daily for 7 days
Number of subjects: 27
Study 2448425 — intervention group
Group type: COMPARATOR
Intervention: Control group without HES infusion
Number of subjects: 27
Study 29924703 — intervention group
Group type: EXPERIMENTAL
Intervention: Protein-enhanced diet (1.2 g protein/kg body weight/day with 30 g protein/meal), n=41
Number of subjects: 67
Study 29924703 — intervention group
Group type: COMPARATOR
Intervention: Control diet (0.8 g protein/kg body weight/day), n=21
Number of subjects: 67
Study 27977890 — intervention group
Group type: EXPERIMENTAL
Intervention: Scissor-type knife supported WJ needle-knife (SB Jr group)
Number of subjects: 85
Study 27977890 — intervention group
Group type: COMPARATOR
Intervention: WJ needle-knife alone (Flush group)
Number of subjects: 85
Study 27977890 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 85
Study 26850888 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimized group 1 (individualized treatment in 30 DM cases)
Number of subjects: 178
Study 26850888 — intervention group
Group type: COMPARATOR
Intervention: Retreatment group 1 (standard retreatment regimen in 30 DM cases)
Number of subjects: 178
Study 26850888 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimized group 2 (individual regimen in 57 non-DM cases)
Number of subjects: 178
Study 26850888 — intervention group
Group type: COMPARATOR
Intervention: Retreatment group 2 (standard retreatment regimen in 61 non-DM cases)
Number of subjects: 178
Study 23298380 — intervention group
Group type: EXPERIMENTAL
Intervention: Rilpivirine 25 mg once daily
Number of subjects: 0
Study 23298380 — intervention group
Group type: COMPARATOR
Intervention: Efavirenz 600 mg once daily
Number of subjects: 0
Study 21636239 — intervention group
Group type: EXPERIMENTAL
Intervention: Protégé EverFlex 200-mm-long self-expanding nitinol stent
Number of subjects: 100
Study 18974579 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous vitamin C (300 mg with each dialysis session)
Number of subjects: 132
Study 18974579 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 132
Study 16492717 — intervention group
Group type: EXPERIMENTAL
Intervention: Fontolizumab 0.1 mg/kg
Number of subjects: 45
Study 16492717 — intervention group
Group type: EXPERIMENTAL
Intervention: Fontolizumab 1.0 mg/kg
Number of subjects: 45
Study 16492717 — intervention group
Group type: EXPERIMENTAL
Intervention: Fontolizumab 4.0 mg/kg
Number of subjects: 45
Study 16492717 — intervention group
Group type: EXPERIMENTAL
Intervention: Fontolizumab (all doses)
Number of subjects: 45
Study 16492717 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study 14656778 — intervention group
Group type: EXPERIMENTAL
Intervention: 6% hydroxyethylstarch (HES 130/0.4)
Number of subjects: 36
Study 14656778 — intervention group
Group type: COMPARATOR
Intervention: Lactated Ringers solution (RL)
Number of subjects: 36
Study 10840987 — intervention group
Group type: EXPERIMENTAL
Intervention: Tomato juice (500 ml/day)
Number of subjects: 57
Study 10840987 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin E (800 U/day)
Number of subjects: 57
Study 10840987 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin C (500 mg/day)
Number of subjects: 57
Study 10840987 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 57
Study 9412748 — intervention group
Group type: EXPERIMENTAL
Intervention: sodium hypochlorite 0.25% (SH)
Number of subjects: 20
Study 9412748 — intervention group
Group type: EXPERIMENTAL
Intervention: iodine 1% in ethanol 70% (IE)
Number of subjects: 20
Study 9412748 — intervention group
Group type: EXPERIMENTAL
Intervention: chlorhexidine 4% (CH)
Number of subjects: 20
Study 9412748 — intervention group
Group type: EXPERIMENTAL
Intervention: chlorhexidine 0.5% in ethanol 70% (CE)
Number of subjects: 20
Study 9412748 — intervention group
Group type: EXPERIMENTAL
Intervention: ethanol 70% (ET)
Number of subjects: 20
Study 9412748 — intervention group
Group type: EXPERIMENTAL
Intervention: povidone‐iodine 10% (PI)
Number of subjects: 20
Study 8466723 — intervention group
Group type: EXPERIMENTAL
Intervention: Isradipine
Number of subjects: 883
Study 8466723 — intervention group
Group type: COMPARATOR
Intervention: Hydrochlorothiazide
Number of subjects: 883
Study 30389027 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.250 × 10^6 Df‐C per kg/BW
Number of subjects: 40
Study 30389027 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 × 10^6 Df‐C per kg/BW
Number of subjects: 40
Study 30389027 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 × 10^6 Df‐C per kg/BW
Number of subjects: 40
Study 30389027 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 40
Study 28854883 — intervention group
Group type: EXPERIMENTAL
Intervention: Peg‐IFNα‐2a + entecavir (ETV)
Number of subjects: 178
Study 28854883 — intervention group
Group type: EXPERIMENTAL
Intervention: Peg‐IFNα‐2a + adefovir dipivoxil (ADV)
Number of subjects: 178
Study 28854883 — intervention group
Group type: COMPARATOR
Intervention: Peg‐IFNα‐2a (control)
Number of subjects: 178
Study 23879615 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate functional loading implants (test group 1) with conventional drilling procedure
Number of subjects: 151
Study 23879615 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate functional loading implants (test group 2) with modified implant installation procedure (osteotome technique)
Number of subjects: 151
Study 23879615 — intervention group
Group type: COMPARATOR
Intervention: Conventional drilling procedure with submerged implants for 3 months (control group)
Number of subjects: 151
Study 23879615 — intervention group
Group type: EXPERIMENTAL
Intervention: All implants (combined data)
Number of subjects: 151
Study 24348619 — intervention group
Group type: EXPERIMENTAL
Intervention: Infiltration technique
Number of subjects: 40
Study 24348619 — intervention group
Group type: COMPARATOR
Intervention: I.A nerve block
Number of subjects: 40
Study 21951832 — intervention group
Group type: EXPERIMENTAL
Intervention: sitagliptin 100 mg qd
Number of subjects: 1021
Study 21951832 — intervention group
Group type: COMPARATOR
Intervention: sulphonylurea
Number of subjects: 1021
Study 21951832 — intervention group
Group type: EXPERIMENTAL
Intervention: sitagliptin
Number of subjects: 1021
Study 21951832 — intervention group
Group type: EXPERIMENTAL
Intervention: sitagliptin and sulphonylurea
Number of subjects: 1021
Study 18165450 — intervention group
Group type: EXPERIMENTAL
Intervention: Long chain triglycerides (LCT) infusion for 5 days postoperatively
Number of subjects: 60
Study 18165450 — intervention group
Group type: COMPARATOR
Intervention: Control group (no LCT infusion)
Number of subjects: 60
Study 17198491 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental nutritional formula (EXP) 240 mL/d for 4 weeks before and 6 weeks after influenza vaccination
Number of subjects: 157
Study 14528469 — intervention group
Group type: EXPERIMENTAL
Intervention: Antegrade AoI net blood flow (Group 1)
Number of subjects: 72
Study 14528469 — intervention group
Group type: EXPERIMENTAL
Intervention: Retrograde AoI net blood flow (Group 2)
Number of subjects: 72
Study 14528469 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 72
Study 10928427 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal progesterone gel, 90 mg
Number of subjects: 8
Study 10928427 — intervention group
Group type: COMPARATOR
Intervention: i.m. progesterone formulation, 50 mg
Number of subjects: 8
Study 8628712 — intervention group
Group type: COMPARATOR
Intervention: Formula containing no fiber
Number of subjects: 80
Study 8628712 — intervention group
Group type: EXPERIMENTAL
Intervention: Formula containing 7 gms/L of fiber
Number of subjects: 80
Study 8628712 — intervention group
Group type: EXPERIMENTAL
Intervention: Formula containing 14 gms/L of fiber
Number of subjects: 80
Study 8628712 — intervention group
Group type: EXPERIMENTAL
Intervention: Broad spectrum antibiotics
Number of subjects: 80
Study 8628712 — intervention group
Group type: COMPARATOR
Intervention: Continuous feedings
Number of subjects: 80
Study 8628712 — intervention group
Group type: EXPERIMENTAL
Intervention: Interval feedings
Number of subjects: 80
Study 1568887 — intervention group
Group type: EXPERIMENTAL
Intervention: Stapedectomy
Number of subjects: 91
Study 1568887 — intervention group
Group type: EXPERIMENTAL
Intervention: Stapedotomy
Number of subjects: 91